# Zeshan Muhammedi

> Zeshan Muhammedi is a seed investor at MBX Capital backing Health Care and B2B. See 4 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [MBX Capital](https://shizune.co/investors/profile/mbx-capital)
- Location: New York, United States
- Total investments: 4
- Last investment: Jun 2023
- Lead investor: 25%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/zeshanmuhammedi/

Zeshan Muhammedi is a seed investor at MBX Capital in New York focused on Health Care and B2B. Zeshan Muhammedi is the Co-founder & Managing Partner at MBX Capital. he attended Emory University.

## Contacts

5 contacts available for Zeshan Muhammedi: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/zeshan-muhammedi?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| B2B | 1 | 25% |
| Biopharma | 1 | 25% |
| Electronics | 1 | 25% |
| Hospitality | 1 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series A | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Macro Trials | Developer of a precision research clinical platform designed to bring therapeutics to market. The company provides an infrastructure to reduce the complexity of distributed trials that includes new site activation and site monitoring, enabling investigators and patients to facilitate and optimize clinical research. | $6M | Seed | Jun 21, 2023 | https://www.macrotrials.com |
| ixlayer | ixlayer is an industry leader in the health-tech ecosystem, providing innovative solutions for enabling health systems, payors, biopharma, and health-focused companies to offer health testing in a virtual environment. The ixlayer platform delivers end-to-end solutions for the technical, security, regulatory, and user experience components ofcomplex health testing. As the industry shifts to remote and virtual care options, ixlayer is powering patient engagement and preventative health strategies through virtual health testing, at scale. The ixlayer solution can be added to existing patient engagement platforms and patient portals to enable real time health and wellness lab testing. Founded in 2018, ixlayer currently supports millions of patients and has launched hundreds of testing programs for large organizations, health systems and every level of the government. | $75M | Series A | Mar 11, 2021 | https://ixlayer.com/ |
| SecureAire | SecureAire is a developer of an active particle control technology used to increase the overall filtration efficiency. Its technology removes small critical particles, such as bacteria, viruses, allergens, TVOC, gasses, and odors indoors by reducing or eliminating harmful particles, enabling hospitals, commercial buildings, and homes to improve airquality, prevent sick building syndrome, and the spread of dangerous airborne pathogens. |  | Venture - Series Unknown | Dec 01, 2020 | https://secureaire.com/ |

3 of 4 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 4 deals together
- [Accenture Ventures](https://shizune.co/investors/profile/accenture-ventures) — VC Fund, 2 deals together
- Biospring Partners — VC Fund, 2 deals together
- [Pear VC](https://shizune.co/investors/profile/pejman-mar-ventures) — VC Fund, 2 deals together
- [Plug and Play](https://shizune.co/investors/profile/plug-and-play-ventures) — VC Fund, 2 deals together
- [Salesforce Ventures](https://shizune.co/investors/profile/salesforce-ventures) — VC Fund, 2 deals together

## About MBX Capital

VC Fund · New York, United States

MBX Capital is a venture capital partnership investing in early-stage healthcare, life sciences, and environmental health companies

5 contacts available at MBX Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Elizabeth Burstein | Venture Partner | https://shizune.co/investors/profile/elizabeth-burnstein |
| Gurdane Bhutani | Co-founder & Managing Partner | https://shizune.co/investors/profile/gurdane-bhutani |
| Martin Gargaros | Director | https://shizune.co/investors/profile/martin-gargaros-196d |
| Puneet Sapra | Venture Partner | https://shizune.co/investors/profile/puneet-sapra |
| Zeshan Muhammedi | Co-founder & Managing Partner | https://shizune.co/investors/profile/zeshan-muhammedi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Zeshan Muhammedi invest in?

Zeshan Muhammedi invests primarily in Health Care, B2B and Biopharma startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Zeshan Muhammedi?

Public channels for Zeshan Muhammedi include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Zeshan Muhammedi last invest?

The most recent investment recorded for Zeshan Muhammedi closed in Jun 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co